Wei et al., Zhongguo Yaoli Xuebao, 12(5), 406-10 Abstract Only, 1991.* |
Lievano et al., Methods Find. Exp. Clin. Pharmacol., 18(10), 659-662 Abstract Only, 1996.* |
Gu et al. (1995), “Isolation, Purification, and Characterization of Immunosuppressive Compounds from Tripterygium: Triptolide and Tripdiolide,” Int. J. Immunopharmac., vol. 17(5):351-356. |
Lee et al. (1999), “PG490 (Triptolide) Cooperates with Tumor Necrosis Factor-α to Induce Apoptosis in Tumor Cells,” Journal of Biochemistry, vol. 274(19):18451-18455. |
Qiu et al. (1999), “Immunosuppressant PG490 (Triptolide) Inhibits T-cell Interleukin-2 Expression at the Level of Purine-box Nuclear Factor of Activated T-cells and NF-κB Transcriptional Activation,” Journal of Biological Chemistry, vol. 274(19):13443-13450. |
Shamon et al. (1997), “Evaluation of the Mutagenic, Cytotoxic, and Antitumor Potential of Triptolide, a Highly Oxygenated Diterpene Isolated from Tripterygium Wilfordii,” Cancer Letters, vol. 112:113-117. |
Tengchaisri et al. (1998), “Antitumor Activity of Triptolide Against Cholangiocarcinoma Growth in Vitro and in Hamsters,” Cancer Letters, vol. 133:169-175. |
Yang et al. (1998), “Triptolide Induces Apoptotic Death of T lymphocyte,” Immunopharmacology, vol. 40:139-149. |